Biotech secures CRISPR patent for COVID-19 diagnostic test

21-02-2023

Liz Hockley

Biotech secures CRISPR patent for COVID-19 diagnostic test

vchal / Shutterstock.com

Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.


CRISPR, Sherlock Biosciences, Cas9 enzyme, Cas12 enzyme, COVID-19, diagnostics

LSIPR